Table 3. Secondary cognitive outcomes specific for MCI.
Treatment | T0 | T1 | T2 | Between-groups comparison (Treatment) |
||
TMT-A (sec.) | PT | 95.6±15 | 82±12.2 | 94±17.3 | ★✦☆✧ | |
CT | 87.6±28.2 | 97±47.1 | 97.1±36.3 | |||
CTRL | 111.8±64.9 | 149.1±68.8 | 180.7±62.6 | ▲ ■ | ||
TMT-B (sec.) | PT | 209.1±48.7 | 190.1±30.6 | 195.7±39.8 | ★✦☆✧ | |
CT | 193.9±56.5 | 173.1±53.3 | 215.2±76.5 | |||
CTRL | 233±67.2 | 297.3±71 | 331.4±54.7 | ▲ ■ | ||
RBMT (0-212) | PT | 79±29.1 | 93.6±35.6 | 81.7±37 | ▲ | ★✦☆✧ |
CT | 77±30.3 | 95.1±31.4 | 74.5±36.2 | ▲ | ||
CTRL | 66.2±22.3 | 51.6±25.4 | 38.3±21.1 | ▲ ■ |
Data are given ad mean ± standard deviation. Abbreviations: PT: Physical Treatment group; CT: Cognitive Treatment group; CTRL: Control group. TMT: Trail Making Test; RBMT: Rivermead Behavioral Memory Test; FAB: Frontal Assessment Battery; IADL: Instrumental Activity of Daily Living; NPI: Neuropsychiatric Inventory. T0: Pre-Treatment assessment; T1: Post-Treatment assessment; T2: Follow-p assessment.
Within-group comparison significant results (p ≤ 0.05): ▲ T0-T1; ■ T0-T2.
Between-groups significant results (p ≤ 0.05): ★ T1 PT vs T1 CTRL; ✦ T1 CT vs T1 CTRL; ☆ T2 PT vs T2 CTRL; ✧ T2 CT vs T2 CTRL